BridgeMD
Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy
EU CTIS ID: 2024-513435-24-01
What this study is testing
To demonstrate that at least 1 dose of LY3848575 is superior to placebo in pain intensity
- Therapeutic exploratory (Phase II)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Are at least 18 years or older old at time of ICF signature.
- Have moderate to severe pain nerve pain at least 6 months prior to screening.
- Are willing to discontinue all medications taken for chronic pain conditions.
- Not be able to become pregnant.
You likely can't join if
- Have other sources of pain that interfere with assessing nerve pain
- Have uncontrolled diabetes.
- Have a surgery planned.
- Have had chemotherapy for cancer in the last year that led to nerve pain
- Have history within 2 years of study entry of alcohol or substance use disorder
The study team makes the final eligibility decision.
Where it's taking place
- Canada
- United States
- Mexico
- Korea, Republic of
- Japan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Canada; United States; Mexico; Korea, Republic of; Japan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.